A task force of the Canadian Breast Cancer Research Initiative has reviewed available information on Essiac, green tea, Iscador, hydrazine sulfate, vitamins A, C and E, and 714-X. The findings summarized in each article will provide physicians and patients with reliable information in this area. Accompanying the series is a general patient-information piece designed to assist people who are considering unconventional therapies and to promote open communication between patients and providers.

1. Essiac (vol. 158, no. 7)
2. Green tea (vol. 158, no. 8)
3. Iscador (vol. 158, no. 9)
4. Hydrazine sulfate (vol. 158, no. 10)
5. Vitamins A, C and E (vol. 158, no. 11)
6. 714-X (vol. 158, no. 12)